Multi Ways Holdings Files Annual Report on Form 20-F for Fiscal Year 2024
The 2024 Annual Report can be accessed directly at https://www.sec.gov/ix?doc=/Archives/edgar/data/0001941500/000164117225012321/form20-f.htm.
In addition, Multi Ways shareholders may receive a hard copy of the Company's complete audited financial statements free of charge by requesting a copy from the contact below.
Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.com
About Multi Ways Holdings Limited
Multi Ways Holdings supplies a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. With more than two decades of experience in the sales and rental of heavy construction equipment business, the Company is widely established as a reliable supplier of new and used heavy construction equipment to customers from Singapore, Australia, UAE, Maldives, Indonesia, and the Philippines. With our wide variety of heavy construction equipment in our inventory and complementary equipment refurbishment and cleaning services, Multi Ways is well-positioned to serve customers as a one-stop shop. For more information, visit www.multiwaysholdings.com.
Safe Harbor StatementThis press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' or 'hopes' or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer
By GlobeNewswire Published on July 15, 2025, 16:00 IST CHICAGO, July 15, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) ('Verano' or the 'Company'), a leading multi-state cannabis company, today announced the promotion and appointment of James Leventis as the Company's Chief Strategy and Compliance Officer, effective as of July 1, 2025. As the newest member of Verano's executive leadership team, Leventis will provide strategic leadership over the Company's robust regulatory, licensing, compliance and government affairs activities across its expanding national footprint. Since joining the Company in 2019, he has played a critical role driving Verano's growth from a single-state operator to one of the industry's largest publicly traded companies. A seasoned cannabis executive and licensed attorney, Leventis most recently served as Executive Vice President of Legal, Regulatory and Government Affairs for the Company, and his nearly 15-year career spans a variety of disciplines including regulatory, compliance, M&A and licensing in the healthcare, pharmaceutical, consulting and cannabis sectors. Leventis also plays a pivotal external role advocating for cannabis reform at the state and federal levels. Throughout his tenure, he has served as a founding member and executive officer on a number of boards, trade associations and political action committees, including the United States Cannabis Roundtable, the American Rights and Reform PAC, the American Trade Association of Cannabis and Hemp, and more. 'Given his extensive experience, industry knowledge and advocacy, I am thrilled to announce James's promotion to Chief Strategy and Compliance Officer, and am confident that his unique skill sets and expertise will further strengthen our executive leadership team,' said George Archos, Verano founder and Chief Executive Officer. 'As we navigate the dynamic cannabis sector, I believe Verano, and the industry at large, will benefit from James's ongoing leadership and influence supporting important initiatives and legislative advancements, and we look forward to his contributions for years to come.' About Verano Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry's leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, including Cabbage Club™, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano's active operations span 13 U.S. states, comprised of 15 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Contacts: MediaVeranoGrace BondyDirector, Communications [email protected] Investors [email protected] Forward Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as 'plans', 'expects' or 'does not expect', 'is expected', 'budget', 'future', 'scheduled', 'estimates', 'forecasts', 'projects,' 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases, or may contain statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will be taken', 'will continue', 'will occur' or 'will be achieved'. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company's annual report on Form 10-K for the year ended December 31, 2024 and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements. ### Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
an hour ago
- Business Upturn
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. ('Perspective' or the 'Company') (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that it will report its second quarter 2025 financial results and provide a business update on Wednesday, August 13, 2025 before the market opens. The press release will be available on the newsroom section of the Company's website at About Perspective Therapeutics, Inc. Perspective Therapeutics, Inc. is a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. The Company is also developing complementary imaging diagnostics that incorporate the same targeting moieties, which provides the opportunity to personalize treatment and optimize patient outcomes. This 'theranostic' approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01), neuroendocrine tumor (VMT-α-NET), and solid tumor (PSV359) programs are in Phase 1/2a imaging and therapy trials in the U.S. The Company is growing its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations. For more information, please visit the Company's website at Safe Harbor Statement This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements concerning, among other things, the Company's ability to pioneer advanced treatments for cancers throughout the body; the ability of the Company's proprietary technology utilizing the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties; the Company's prediction that the use of complementary imaging diagnostics that incorporate the same targeting moieties provides the opportunity to personalize treatment and optimize patient outcomes; the Company's belief that its 'theranostic' approach enables the ability to see a specific tumor and then treat it to potentially improve efficacy and minimize toxicity; the Company's ability to grow its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations; and other statements that are not historical fact. These forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from the results described in or implied by the forward-looking statements. Certain factors that may cause the Company's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are described under the heading 'Risk Factors' in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the 'SEC'), in the Company's other filings with the SEC, and in the Company's future reports to be filed with the SEC and available at Forward-looking statements contained in this news release are made as of this date. Unless required to do so by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Media and Investor Relations Contacts: Perspective Therapeutics IR:Annie J. Cheng, CFA [email protected]
Business Wire
an hour ago
- Business Wire
Albertsons Companies, Inc. Reports First Quarter Fiscal 2025 Results
BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. (NYSE: ACI) (the "Company") today reported results for the first quarter of fiscal 2025, which ended June 14, 2025. First Quarter of Fiscal 2025 Highlights Identical sales increased 2.8% Digital sales increased 25% Loyalty members increased 14% to 47.3 million Net income of $236 million, or $0.41 per share Adjusted net income of $319 million, or $0.55 per share Adjusted EBITDA of $1,111 million "In the first quarter, we delivered solid operating and financial performance, while investing in our core operations and improving our customer value proposition," said Susan Morris, Chief Executive Officer. "Ongoing investments in our strategic priorities drove increased engagement across our digital platforms, evidenced by strong growth in our digital sales, pharmacy operations, and membership in our loyalty program. To fuel these investments, we leveraged our productivity engine to drive efficiencies throughout our operations." Morris added, "As we look forward to the balance of fiscal 2025, we do so with continued confidence in our Customers for Life strategy. We want to thank our teams for delivering these results and for their ongoing commitment to serving our customers and supporting the communities in which we operate." First Quarter of Fiscal 2025 Results Net sales and other revenue increased 2.5% to $24,880.8 million for the 16 weeks ended June 14, 2025 ("first quarter of fiscal 2025") from $24,265.4 million during the 16 weeks ended June 15, 2024 ("first quarter of fiscal 2024"). This increase was driven by a 2.8% increase in identical sales, with strong growth in pharmacy sales being the primary driver of the identical sales increase. We also continued to grow our digital sales with a 25% increase during the first quarter of fiscal 2025. These increases in Net sales and other revenue were partially offset by lower fuel sales. Gross margin rate decreased to 27.1% during the first quarter of fiscal 2025 compared to 27.8% during the first quarter of fiscal 2024. Excluding the impact of fuel and LIFO expense, gross margin rate decreased 85 basis points compared to the first quarter of fiscal 2024. This decrease in gross margin rate was primarily driven by incremental investments in our customer value proposition, strong growth in pharmacy sales, which carries an overall lower gross margin rate, and increases in delivery and handling costs related to the continued growth in our digital sales, partially offset by the benefits from our productivity initiatives, which included reductions in shrink expense. Selling and administrative expenses decreased to 25.4% of Net sales and other revenue during the first quarter of fiscal 2025 compared to 25.9% during the first quarter of fiscal 2024. Excluding the impact of fuel, Selling and administrative expenses as a percentage of Net sales and other revenue decreased 63 basis points. This decrease in Selling and administrative expenses as a percentage of Net sales and other revenue was primarily attributable to lower merger-related costs, the leveraging of employee costs and operating expenses related to the continued development of our digital platforms and modernization of our technology, partially offset by increases in legal, professional and outside services as well as business transformation costs. The benefits from our productivity initiatives continue to help offset increasing wage rates and other inflationary pressures on our operating expenses. Net gain on property dispositions and impairment losses was $31.9 million during the first quarter of fiscal 2025 compared to net loss of $5.3 million during the first quarter of fiscal 2024. Interest expense, net was $141.8 million during the first quarter of fiscal 2025 compared to $145.7 million during the first quarter of fiscal 2024. This decrease in interest expense, net was primarily attributable to lower average outstanding borrowings. Other income, net was $3.9 million during the first quarter of fiscal 2025 compared to other expense, net of $4.0 million during the first quarter of fiscal 2024. Income tax expense was $75.0 million during the first quarter of fiscal 2025, representing a 24.1% effective tax rate, compared to $69.2 million during the first quarter of fiscal 2024, representing a 22.3% effective tax rate. This increase in the effective rate was primarily driven by the reduction of a reserve for an uncertain tax position due to the expiration of a state statute in the first quarter of fiscal 2024. Net income was $236.4 million, or $0.41 per share, during the first quarter of fiscal 2025, compared to $240.7 million, or $0.41 per share, during the first quarter of fiscal 2024. Adjusted net income was $318.9 million, or $0.55 per share, during the first quarter of fiscal 2025, compared to $391.6 million, or $0.66 per share, during the first quarter of fiscal 2024. Adjusted EBITDA was $1,111.0 million, or 4.5% of Net sales and other revenue, during the first quarter of fiscal 2025 compared to $1,183.9 million, or 4.9% of Net sales and other revenue, during the first quarter of fiscal 2024. Capital Allocation and Common Stock Repurchase Program During the first quarter of fiscal 2025, capital expenditures were $584.6 million, which primarily included the completion of 36 remodels, the opening of three new stores and continued investment in our digital and technology platforms. During the first quarter of fiscal 2025, the Company paid its quarterly dividend of $0.15 per share on May 9, 2025 to stockholders of record as of April 25, 2025. On July 15, 2025, the Company announced the next quarterly dividend payment of $0.15 per share to be paid on August 8, 2025 to stockholders of record as of the close of business on July 25, 2025. During the first quarter of fiscal 2025, the Company repurchased 14.2 million shares of common stock for a total of $314.8 million pursuant to the existing multi-year $2.0 billion repurchase authorization. On March 11, 2025, the Company completed the issuance of $600.0 million in aggregate principal amount of 6.250% senior unsecured notes due March 15, 2033 (the "2033 Notes"). On March 17, 2025, proceeds from the 2033 Notes were used to redeem in full the $600.0 million outstanding of 7.500% senior unsecured notes due March 15, 2026. Fiscal 2025 Outlook The Company is providing an updated fiscal 2025 outlook and expects its financial results to be as follows: Identical sales growth in the range of 2.0% to 2.75% (previously 1.5% to 2.5%) Adjusted EBITDA in the range of $3.8 billion to $3.9 billion, including approximately $65 million related to the Company's 53rd week (unchanged) Adjusted net income per Class A common share in the range of $2.03 to $2.16 per share (unchanged) Effective income tax rate in the range of 23.5% to 24.5% (unchanged) Capital expenditures in the range of $1.7 billion to $1.9 billion (unchanged) The Company is unable to provide a full reconciliation of the GAAP and Non-GAAP Measures (as defined below) used in the updated fiscal 2025 outlook without unreasonable effort because it is not possible to predict certain of the adjustment items with a reasonable degree of certainty. This information is dependent upon future events and may be outside of the Company's control and could have a significant impact on its GAAP financial results for fiscal 2025. The expected effective tax rate does not reflect potential future rate adjustments for the resolution of tax audits or potential changes in tax laws, which cannot be predicted with reasonable certainty. Conference Call The Company will hold a conference call today at 8:30 a.m. Eastern Time, which will be hosted by Susan Morris, CEO, and Sharon McCollam, President & CFO. The call will be webcast and can be accessed at A replay of the webcast will be available for at least two weeks following the completion of the call. About Albertsons Companies Albertsons Companies is a leading food and drug retailer in the United States. As of June 14, 2025, the Company operated 2,264 retail stores with 1,725 in-store pharmacies, 408 associated fuel centers, 22 dedicated distribution centers and 19 manufacturing facilities. The Company operates stores across 35 states and the District of Columbia under 22 well known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Kings Food Markets and Balducci's Food Lovers Market. The Company is committed to helping people across the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2024, along with the Albertsons Companies Foundation, the Company contributed more than $435 million in food and financial support, including more than $40 million through our Nourishing Neighbors Program to ensure those living in our communities and those impacted by disasters have enough to eat. Albertsons, Safeway, Vons, Jewel-Osco, Tom Thumb, Randalls, United Supermarkets, Pavilions, Haggen and Balducci's Food Lovers Market are registered trademarks of Albertsons Companies Inc. or its subsidiaries. ACME, Carrs, Kings Food Markets, Shaw's, and Star Market are trademarks of Albertsons Companies Inc. or its subsidiaries. Albertsons associated logos, product names and services are trademarks of Albertsons Companies, Inc. All other trademarks are the property of their respective owners. Forward-Looking Statements and Factors That Impact Our Operating Results and Trends This press release includes "forward-looking statements" within the meaning of the federal securities laws. The "forward-looking statements" include our current expectations, assumptions, estimates and projections about our business and our industry. They include statements relating to our future operating or financial performance which the Company believes to be reasonable at this time. You can identify forward-looking statements by the use of words such as "outlook," "may," "should," "could," "estimates," "predicts," "potential," "continue," "anticipates," "believes," "plans," "expects," "future" and "intends" and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to numerous risks and uncertainties which are beyond our control and difficult to predict and could cause actual results to differ materially from the results expressed or implied by the statements. Risks and uncertainties that could cause actual results to differ materially from such statements and may adversely impact our financial condition and results of operations include: changes in macroeconomic conditions such as rates of food price inflation or deflation, fuel and commodity prices and uncertainty in international trade including current and potential future tariffs; changes in consumer behavior and spending patterns resulting from macroeconomic conditions, including shifts in state and federal assistance programs; changes in wage rates and our ability to negotiate acceptable contracts with labor unions, including the outcome of pending union negotiations; changes in price of goods sold in our stores and cost of goods used in our food products due to changes in various state and federal government regulations; uncertainty regarding the geopolitical environment; our inability to execute on our standalone business and value-creating strategies following the termination of the merger agreement with Kroger due to prolonged uncertainties and restrictions on our business during the pendency of the merger; litigation in connection with the previously pending merger and the termination of the merger agreement, resulting in ongoing costs that we may be required to pay in connection with the lawsuit against Kroger, or our inability to collect the $600 million termination fee from Kroger, and negative reactions from the financial markets and our suppliers, customers, and associates as a result of the litigation; our ability to recruit and retain qualified associates who are critical to the success of our Customers for Life strategy; failure to achieve productivity initiatives, unexpected changes in our objectives and plans, inability to implement our strategies, plans, programs and initiatives, or enter into strategic transactions, investments or partnerships in the future on terms acceptable to us, or at all; challenges with our supply chain; operational and financial effects resulting from cyber incidents at the Company or at a third party, including outages in the cloud environment and the effectiveness of business continuity plans during a ransomware or other cyber incident; and changes in tax rates, tax laws, and regulations that directly impact our business or our customers. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements and risk factors. Forward-looking statements contained in this press release reflect our view only as of the date of this press release. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In evaluating our financial results and forward-looking statements, you should carefully consider the risks and uncertainties more fully described in the "Risk Factors" section or other sections in our reports filed with the SEC including the most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Non-GAAP Measures and Identical Sales Non-GAAP Measures. EBITDA, Adjusted EBITDA, Adjusted net income, Adjusted net income per Class A common share and Net debt ratio (collectively, the "Non-GAAP Measures") are performance measures that provide supplemental information the Company believes is useful to analysts and investors to evaluate its ongoing results of operations, when considered alongside other GAAP measures such as net income, operating income, gross margin, and net income per Class A common share. These Non-GAAP Measures exclude the financial impact of items management does not consider in assessing the Company's ongoing core operating performance, and thereby provide useful measures to analysts and investors of its operating performance on a period-to-period basis. Other companies may have different definitions of Non-GAAP Measures and provide for different adjustments, and comparability to the Company's results of operations may be impacted by such differences. The Company also uses Adjusted EBITDA and Net debt ratio for board of director and bank compliance reporting. The Company's presentation of Non-GAAP Measures should not be construed as an inference that its future results will be unaffected by unusual or non-recurring items. Identical Sales. As used in this earnings release, the term "identical sales" includes stores operating during the same period in both the current fiscal year and the prior fiscal year, comparing sales on a daily basis. Direct to consumer digital sales are included in identical sales, and fuel sales are excluded from identical sales. Albertsons Companies, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in millions) (unaudited) June 14, 2025 February 22, 2025 ASSETS Current assets Cash and cash equivalents $ 151.0 $ 293.6 Receivables, net 908.9 834.8 Inventories, net 4,976.3 4,989.0 Other current assets 380.7 441.6 Total current assets 6,416.9 6,559.0 Property and equipment, net 9,708.0 9,811.0 Operating lease right-of-use assets 6,174.7 6,153.4 Intangible assets, net 2,281.1 2,318.0 Goodwill 1,201.0 1,201.0 Other assets 688.1 713.3 TOTAL ASSETS $ 26,469.8 $ 26,755.7 LIABILITIES Current liabilities Accounts payable $ 3,834.1 $ 4,092.7 Accrued salaries and wages 1,273.3 1,345.2 Current maturities of long-term debt and finance lease obligations 832.1 57.6 Current operating lease obligations 720.3 705.5 Other current liabilities 1,208.1 1,050.0 Total current liabilities 7,867.9 7,251.0 Long-term debt and finance lease obligations 7,005.6 7,762.5 Long-term operating lease obligations 5,756.4 5,657.2 Deferred income taxes 783.8 824.1 Other long-term liabilities 1,831.8 1,875.0 Commitments and contingencies STOCKHOLDERS' EQUITY Class A common stock 6.0 6.0 Additional paid-in capital 2,188.0 2,184.0 Treasury stock, at cost (701.5 ) (386.7 ) Accumulated other comprehensive income 94.3 94.7 Retained earnings 1,637.5 1,487.9 Total stockholders' equity 3,224.3 3,385.9 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 26,469.8 $ 26,755.7 Expand Albertsons Companies, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (in millions) (unaudited) 16 weeks ended June 14, 2025 June 15, 2024 Cash flows from operating activities: Net income $ 236.4 $ 240.7 Adjustments to reconcile net income to net cash provided by operating activities: (Gain) loss on property dispositions and impairment losses, net (31.9 ) 5.3 Depreciation and amortization 572.7 552.0 Operating lease right-of-use assets amortization 214.1 207.6 LIFO expense 17.3 14.6 Deferred income tax (38.0 ) (56.3 ) Contributions to pension and post-retirement benefit plans, net of expense (income) (43.0 ) (10.9 ) Deferred financing costs 6.3 4.9 Equity-based compensation expense 33.7 36.7 Other operating activities 4.1 6.0 Changes in operating assets and liabilities: Receivables, net (73.2 ) (84.5 ) Inventories, net (4.5 ) 210.7 Accounts payable, accrued salaries and wages and other accrued liabilities (114.6 ) (304.0 ) Operating lease liabilities (127.8 ) (125.9 ) Self-insurance assets and liabilities (6.0 ) 21.5 Other operating assets and liabilities 108.8 242.5 Net cash provided by operating activities 754.4 960.9 Cash flows from investing activities: Payments for property, equipment and intangibles, including lease buyouts (584.6 ) (543.0 ) Proceeds from sale of assets 78.2 3.8 Other investing activities 32.3 1.2 Net cash used in investing activities (474.1 ) (538.0 ) Cash flows from financing activities: Proceeds from issuance of long-term debt, including ABL facility 625.0 — Payments on long-term borrowings, including ABL facility (600.2 ) (200.2 ) Payments of obligations under finance leases (10.1 ) (12.5 ) Dividends paid on common stock (85.7 ) (69.5 ) Treasury stock purchase, at cost (314.8 ) — Employee tax withholding on vesting of restricted stock units (31.4 ) (38.6 ) Other financing activities (5.7 ) — Net cash used in financing activities (422.9 ) (320.8 ) Net (decrease) increase in cash and cash equivalents and restricted cash (142.6 ) 102.1 Cash and cash equivalents and restricted cash at beginning of period 297.9 193.2 Cash and cash equivalents and restricted cash at end of period $ 155.3 $ 295.3 Expand Albertsons Companies, Inc. and Subsidiaries Reconciliation of Non-GAAP Measures (in millions, except per share data) The following table reconciles Net income to Adjusted net income and Adjusted EBITDA (in millions): 16 weeks ended June 14, 2025 June 15, 2024 Net income $ 236.4 $ 240.7 Adjustments: Business transformation (1)(b) 38.3 17.3 Equity-based compensation expense (b) 33.7 36.7 (Gain) loss on property dispositions and impairment losses, net (31.9 ) 5.3 LIFO expense (a) 17.3 14.6 Merger-related costs (2)(b) 19.0 92.3 Certain legal and regulatory accruals and settlements, net (b) 2.6 (8.9 ) Amortization of debt discount and deferred financing costs (c) 6.2 4.9 Amortization of intangible assets resulting from acquisitions (b) 14.8 14.7 Miscellaneous adjustments (3)(e) 6.1 19.0 Tax impact of adjustments to Adjusted net income (23.6 ) (45.0 ) Adjusted net income $ 318.9 $ 391.6 Tax impact of adjustments to Adjusted net income 23.6 45.0 Income tax expense 75.0 69.2 Amortization of debt discount and deferred financing costs (c) (6.2 ) (4.9 ) Interest expense, net 141.8 145.7 Amortization of intangible assets resulting from acquisitions (b) (14.8 ) (14.7 ) Depreciation and amortization (d) 572.7 552.0 Adjusted EBITDA $ 1,111.0 $ 1,183.9 Expand The following tables reconcile diluted net income per Class A common share to Adjusted net income per Class A common share (in millions, except per share data): 16 weeks ended June 14, 2025 June 15, 2024 Numerator: Adjusted net income (4) $ 318.9 $ 391.6 Denominator: Weighted average Class A common shares outstanding - diluted 575.4 581.3 Restricted stock units (5) 8.5 9.3 Adjusted weighted average Class A common shares outstanding - diluted 583.9 590.6 Adjusted net income per Class A common share - diluted $ 0.55 $ 0.66 Expand (1) Includes costs associated with third-party consulting fees related to our Customers for Life strategy and employee termination costs. (2) The first quarter of fiscal 2025 primarily relates to litigation costs and retention program expense related to the terminated merger. The first quarter of fiscal 2024 primarily includes third-party legal and advisor fees and retention program expense related to the merger. (3) Primarily includes net realized and unrealized gains and losses related to non-operating investments, lease adjustments related to non-cash rent expense and costs incurred on leased surplus properties, gains and losses on energy hedges and other items not considered in our core performance. (4) See the reconciliation of Net income to Adjusted net income above for further details. (5) Represents incremental unvested restricted stock units ("RSUs") to adjust the diluted weighted average Class A common shares outstanding during each respective period to the fully outstanding RSUs as of the end of each respective period. (6) Reflects the per share impact of Non-GAAP adjustments for each period. See the reconciliation of Net income to Adjusted net income above for further details. Non-GAAP adjustment classifications within the Condensed Consolidated Statements of Operations: (a) Cost of sales (b) Selling and administrative expenses (c) Interest expense, net (d) Depreciation and amortization: Expand 16 weeks ended June 14, 2025 June 15, 2024 Cost of sales $ 64.1 $ 53.6 Selling and administrative expenses 508.6 498.4 Total Depreciation and amortization $ 572.7 $ 552.0 Expand (e) Miscellaneous adjustments: Expand 16 weeks ended June 14, 2025 June 15, 2024 Cost of sales $ (0.5 ) $ 0.1 Selling and administrative expenses 5.6 11.5 Other (income) expense, net 1.0 7.4 Total Miscellaneous adjustments $ 6.1 $ 19.0 Expand Albertsons Companies, Inc. and Subsidiaries Reconciliation of Non-GAAP Measures (in millions) The following table is a reconciliation of Net Debt Ratio on a rolling four quarter basis: June 14, 2025 June 15, 2024 Total debt (including finance leases) $ 7,837.7 $ 7,857.4 Cash and cash equivalents 151.0 291.1 Total debt net of cash and cash equivalents 7,686.7 7,566.3 Rolling four quarters Adjusted EBITDA $ 3,931.8 $ 4,183.1 Total Net Debt Ratio 1.96 1.81 Expand The following table is a reconciliation of Net income to Adjusted EBITDA on a rolling four quarter basis: Rolling four quarters ended June 14, 2025 June 15, 2024 Net income $ 954.3 $ 1,119.5 Depreciation and amortization 1,838.6 1,800.4 Interest expense, net 455.9 482.9 Income tax expense 176.9 296.1 EBITDA 3,425.7 3,698.9 Business transformation (1) 126.2 50.3 Equity-based compensation expense 103.2 109.3 Loss on property dispositions and impairment losses, net 58.6 21.6 LIFO expense 31.3 32.6 Merger-related costs (2) 181.5 225.8 Certain legal and regulatory accruals and settlements, net 17.6 (15.6 ) Miscellaneous adjustments (3) (12.3 ) 60.2 Adjusted EBITDA $ 3,931.8 $ 4,183.1 Expand (1) Includes costs associated with third-party consulting fees related to our Customers for Life strategy and employee termination costs. (2) Primarily includes third-party legal and advisor fees and retention program expense related to the merger. Also includes litigation costs related to the termination of the merger in December 2024. (3) Primarily includes net realized and unrealized gains and losses related to non-operating investments, lease adjustments related to non-cash rent expense and costs incurred on leased surplus properties, pension settlement loss, gains and losses on energy hedges and other items not considered in our core performance. Expand
